The CD4(+) T-cell response of melanoma patients to a MAGE-A3 peptide vaccine involves potential regulatory T cells.
Cancer Res
; 69(10): 4335-45, 2009 May 15.
Article
in En
| MEDLINE
| ID: mdl-19435913
Full text:
1
Database:
MEDLINE
Main subject:
CD4-Positive T-Lymphocytes
/
T-Lymphocytes, Regulatory
/
Cancer Vaccines
/
Vaccines, Subunit
/
Melanoma
/
Antigens, Neoplasm
/
Neoplasm Proteins
Limits:
Humans
Language:
En
Year:
2009
Type:
Article